Poultry
Innovative products and solutions that make a difference, improving poultry health, welfare, and productivity.
Delivering Poultry Solutions and Innovation that Producers can Depend on
For more than 80 years, our poultry health solutions and platforms have always been rooted in discovery. From developing the first vaccine for fowl pox to launching digital health tracking tools, we’re constantly pushing the boundaries of poultry research and development to deliver new solutions to improve flock health, welfare and performance.
Merck Animal Health is dedicated to developing cutting-edge solutions that improve the health, well-being, and performance of poultry.
Chicks
Broilers
Commercial Laying Hens
Breeders
Backyard Chickens
Turkeys
Our Solutions
Vaccines
Disease Prevention to Improve Flock Health
The poultry industry demands innovations to address emerging diseases. Our wide portfolio of vaccines helps protect chickens from major poultry pathogens including infectious bronchitis virus, infectious laryngotracheitis virus, Newcastle disease virus, infectious bursal disease virus, avian reoviruses, coccidiosis and other pathogens.
Parasiticides
Parasite Control That Helps Keep Poultry Healthy
Without proper control and management, parasites can rapidly infect the whole flock and undermine the flock’s performance and health.
We provide solutions to help control internal parasites like coccidiosis, and external parasites, such as poultry red mites.
Explore poultry stories and insights
Enhancing Multivalent Inactivated Vaccines for Long-Living Birds
Poultry is a cornerstone of global food security. It provides affordable, high-quality protein in the form of both meat and eggs, feeding billions of people worldwide.
Merck Animal Health Announces FDA Approval of EXZOLTâ„¢ (fluralaner oral solution) for Chickens, the First Systemic Treatment for Northern Fowl Mites
Innovative oral solution offers a safe and effective approach to combat northern fowl mite infestations in poultry RAHWAY, N.J., July 18, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and
Merck Animal Health Receives Positive CVMP Opinion for INNOVAX®-ND-IBD-ILT for Use in Chickens
RAHWAY, NJ, May 16, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the INNOVAX®-ND-IBD-ILT vaccine.
Merck Animal Health Announces the European Approval of NOBILIS MULTRIVAâ„¢ REOm for Use in ChickensÂ
New vaccine reduces viraemia and clinical signs of disease caused by avian reovirus, expanding NOBILIS MULTRIVA portfolio RAHWAY, N.J., March 27, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that the European Commission has
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen